Results 231 to 240 of about 434,441 (275)

Safety profile of autologous adipose-derived stromal vascular fraction in clinical use: an exhaustive literature review. [PDF]

Stem Cell Res Ther
Nonnarath C, Serratrice N.
europepmc   +1 more source

Advances in hyaluronic acid therapy for knee osteoarthritis: monotherapy and combination strategies: an evidenced based review. [PDF]

Orthop Rev (Pavia)
Cao KX, Tang HNA, Tran MH.
europepmc   +1 more source

Post-marketing safety concerns with trofinetide: a disproportionality analysis of the first therapeutic agent for Rett syndrome based on the FDA adverse event reporting system (FAERS). [PDF]

Front Pharmacol
Yu X, Zhong J, Lin Z, Fu H, Zhang Y.
europepmc   +1 more source

Beyond the label: real-world gastrointestinal adverse events associated with vedolizumab - a decade of FAERS pharmacovigilance. [PDF]

Front Pharmacol
Zheng J, Qiu C, Zhang Z.
europepmc   +1 more source

Clinical efficacy and safety of umbralisib, a dual PI3Kδ/CK1-ϵ inhibitor, in treatment of hematologic malignancies. [PDF]

Front Oncol
Zang Y, Cheng HE, Sun Y, Wang J, Zhao Y, Yang J, Liu Y, Sun Y.   +7 more
europepmc   +1 more source

SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer.

JAMA Netw Open
Udovicich C, Cheung P, Chu W, Chung H, Detsky J, Liu S, Morton G, Tseng CL, Vesprini D, Hudson JM, Ong WL, Kennedy T, Helou J, Davidson M, Ravi A, McGuffin M, Zhang L, Mamedov A, Deabreu A, Kulasingham-Poon M, Loblaw A.   +20 more
europepmc   +1 more source